Home Pharmaceuticals Hikma Pharmaceuticals Page 2

Hikma Pharmaceuticals

Latest

Hikma acquires the rights to a portfolio of Takeda brands for the MENA region

December 20, 2024

Hikma continues strong strategic execution and reiterates guidance

Hikma delivers strong H1 preformance and raises Generics guidance

Good momentum across all businesses and updated Generics guidance

Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region

Hikma strengthens US Injectables business through acquisition of Custopharm

September 29, 2021

Hikma delivers another strong financial and operational performance, and improves FY...

August 8, 2021

Hikma and Melinta Therapeutics sign exclusive licensing agreement for two novel...

April 29, 2021

Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™...

December 1, 2020

Hikma continues strong 2020 performance and updates full year guidance

November 5, 2020

Hikma Announces Expanded Licensing Agreement with Takeda for New Products in...

August 21, 2017

12Page 2 of 2